Lidocaine and prilocaine

Lidocaine and prilocaine is filed as Amide Local Anesthetic [EPC]. The sections below restate public label fields stored for this profile.

Class
Amide Local Anesthetic [EPC]
Dosage forms
Methemoglobinemia: Cases of methemoglobinemia have been reported in association with local anesthetic use. ( 5.1 ) DO NOT INJECT ( 5.2 ) Allergic and anaphylactic reactions can occur ( 5.3 ) Avoid contact with eyes ( 5.4 ) Use with caution in patients with severe hepatic disease ( 5.6 )
Generic available
Yes
Manufacturer
Viona Pharmaceuticals Inc

Warnings and precautions

WARNINGS Application of lidocaine and prilocaine cream to larger areas or for longer times than those recommended could result in sufficient absorption of lidocaine and prilocaine resulting in serious adverse effects (see Individualization of Dose ). Patients treated with class III anti-arrhythmic drugs (e.g., amiodarone, bretylium, sotalol, dofetilide) should be under close surveillance and ECG monitoring considered, because cardiac effects may be additive. Studies in laboratory animals (guinea pigs) have shown that lidocaine and prilocaine cream has an ototoxic effect when instilled into the middle ear. In these same studies, animals exposed to lidocaine and prilocaine cream only in the external auditory canal, showed no abnormality. Lidocaine and prilocaine cream should not be used in any clinical situation when its penetration or migration beyond the tympanic membrane into the middle ear is possible. Methemoglobinemia Cases of methemoglobinemia have been reported in association with local anesthetic use. Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency, congenital or idiopathic methemoglobinemia, cardiac or pulmonary compromise, infants under 6 months of age and concurrent exposure to oxidizing agents or their metabolites are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended. Signs of methemoglobinemia may occur immediately or may be delayed some hours after exposure and are characterized by a cyanotic skin discoloration and/or abnormal coloration of the blood. Methemoglobin levels may continue to rise; therefore, immediate treatment is required to avert more serious central nervous system and cardiovascular adverse effects, including seizures, coma, arrhythmias and death. Discontinue lidocaine and prilocaine cream and any other oxidizing agents. Depending on the severity of the signs and symptoms, patients may respond to supportive care, i.e., oxygen therapy, hydration. A more severe clinical presentation may require treatment with methylene blue, exchange transfusion or hyperbaric oxygen.

Common side effects

N application site reactions were redness (21%); Burning sensation (17%); And edema (10%)

Adverse reactions

Most common adverse reactions (incidence >15%) are application site reactions including pain, soreness, irritation, numbness, ulcerations, vesicles, edema, abscess and/or redness. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact DENTSPLY Pharmaceutical at 1-800-989- 8826 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Drug interactions

Other local anesthetics or agents structurally related to local anesthetics ( 7.1 ) Drugs That May Cause Methemoglobinemia When Used With ORAQIX ( 7.2 )

Common questions

What class of drug is Lidocaine and prilocaine?

Lidocaine and prilocaine belongs to the Amide Local Anesthetic [EPC] class of medications.

What form does Lidocaine and prilocaine come in?

The FDA label lists Lidocaine and prilocaine as: Methemoglobinemia: Cases of methemoglobinemia have been reported in association with local anesthetic use. ( 5.1 ) DO NOT INJECT ( 5.2 ) Allergic and anaphylactic reactions can occur ( 5.3 ) Avoid contact with eyes ( 5.4 ) Use with caution in patients with severe hepatic disease ( 5.6 ). Available strengths and packaging vary by manufacturer.

Is there a generic version of Lidocaine and prilocaine?

Yes. A generic version of Lidocaine and prilocaine is available in the U.S. Ask your pharmacist about substitution.

Does Lidocaine and prilocaine have a Boxed Warning?

Our ingest of the FDA label for Lidocaine and prilocaine does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.

Is Lidocaine and prilocaine currently under recall?

The FDA Enforcement Report does not show an active/ongoing recall for Lidocaine and prilocaine in our latest ingest. Recall data can change daily — verify at FDA.gov.

Who makes Lidocaine and prilocaine?

The FDA label lists Viona Pharmaceuticals Inc as a labeler/manufacturer of Lidocaine and prilocaine. Multiple firms may market generics of the same molecule.

On this site

Related medications in this class or category

Loading full data from Know Your Drugs Institute…